The weekly litigation news digest is live. Subscribe now

IP Verse

Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients - EP3531133

The patent EP3531133 was granted to Amgen on Aug 23, 2023. The application was originally filed on May 20, 2015 under application number EP18213926A. The patent is currently recorded with a legal status of "Revoked".

EP3531133

AMGEN
Application Number
EP18213926A
Filing Date
May 20, 2015
Status
Revoked
Jan 24, 2025
Publication Date
Aug 23, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEMay 21, 2024CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0623679
DESCRIPTIONWO2004106381
DESCRIPTIONWO2007068354
DESCRIPTIONWO2007131092
DESCRIPTIONWO2008119565
DESCRIPTIONWO2008119566
DESCRIPTIONWO2008119567
DESCRIPTIONWO2010052013
DESCRIPTIONWO2010052014
DESCRIPTIONWO2011051307
DESCRIPTIONWO2012146394
DESCRIPTIONWO9954440
OPPOSITIONWO2010052013

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents